Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Earl

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1997
The optimal duration of adjuvant tamoxifen treatment for breast cancer remains uncertain: randomize into aTTomH Earl, R Gray, D Kerr, et al.
Cell Cycle (Georgetown, Tex.)|December 19, 2006
Genome maintenance and mutagenesis in embryonic stem cellsQing Lin, Sarah L Donahue, H Earl Ruley
British Journal of Obstetrics and Gynaecology|March 1, 1993
Percutaneous nephrostomies in women with cervical cancerS Kehoe, D M Luesley, J Budden, et al.
British Journal of Cancer|July 17, 1998
Psychological predictors of attendance at annual breast screening examinationsM V Burton, R Warren, D Price, et al.
The Annals of Otology, Rhinology, and Laryngology|October 29, 2010
Report of the Third Air Force Irradiation Unit, 31 August 1945J J GRAUBER, J W SMITH, D H EARL
Plos One|July 15, 2014
Cell-permeable parkin proteins suppress Parkinson disease-associated phenotypes in cultured cells and animalsTam Duong, Jaetaek Kim, H Earl Ruley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 15, 2014
Anthracyclines and taxanes in the neo/adjuvant treatment of breast cancer: does the sequence matter?J Bines, H Earl, A C Buzaid, et al.
Histopathology|April 24, 2007
Laboratory handling and histology reporting of breast specimens from patients who have received neoadjuvant chemotherapyS E Pinder, E Provenzano, H Earl, et al.
International Journal of Oncology|May 6, 2011
Quantitative analysis of vascular endothelial growth factor expression in chronic lymphocytic leukaemiaD Baban, J Murray, H Earl, et al.
European Journal of Cancer (Oxford, England : 1990)|September 1, 1995
Assessment of five serum marker assays in patients with advanced breast cancer treated with medroxyprogesterone acetateA Murray, O Clinton, H Earl, et al.
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1997
The optimal duration of adjuvant tamoxifen treatment for breast cancer remains uncertain: randomize into aTTomH Earl, R Gray, D Kerr, et al.
Cell Cycle (Georgetown, Tex.)|December 19, 2006
Genome maintenance and mutagenesis in embryonic stem cellsQing Lin, Sarah L Donahue, H Earl Ruley
British Journal of Obstetrics and Gynaecology|March 1, 1993
Percutaneous nephrostomies in women with cervical cancerS Kehoe, D M Luesley, J Budden, et al.
British Journal of Cancer|July 17, 1998
Psychological predictors of attendance at annual breast screening examinationsM V Burton, R Warren, D Price, et al.
The Annals of Otology, Rhinology, and Laryngology|October 29, 2010
Report of the Third Air Force Irradiation Unit, 31 August 1945J J GRAUBER, J W SMITH, D H EARL
Plos One|July 15, 2014
Cell-permeable parkin proteins suppress Parkinson disease-associated phenotypes in cultured cells and animalsTam Duong, Jaetaek Kim, H Earl Ruley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 15, 2014
Anthracyclines and taxanes in the neo/adjuvant treatment of breast cancer: does the sequence matter?J Bines, H Earl, A C Buzaid, et al.
Histopathology|April 24, 2007
Laboratory handling and histology reporting of breast specimens from patients who have received neoadjuvant chemotherapyS E Pinder, E Provenzano, H Earl, et al.
International Journal of Oncology|May 6, 2011
Quantitative analysis of vascular endothelial growth factor expression in chronic lymphocytic leukaemiaD Baban, J Murray, H Earl, et al.
European Journal of Cancer (Oxford, England : 1990)|September 1, 1995
Assessment of five serum marker assays in patients with advanced breast cancer treated with medroxyprogesterone acetateA Murray, O Clinton, H Earl, et al.
Pageof 8